Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C20H16ClN5O2 |
| Molecular Weight | 393.826 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@H](O)[C@@H](NC1=C(C)C(Cl)=C(C=C1)C#N)C2=NN=C(O2)C3=CC=C(C=C3)C#N
InChI
InChIKey=XMBUPPIEVAFYHO-KPZWWZAWSA-N
InChI=1S/C20H16ClN5O2/c1-11-16(8-7-15(10-23)17(11)21)24-18(12(2)27)20-26-25-19(28-20)14-5-3-13(9-22)4-6-14/h3-8,12,18,24,27H,1-2H3/t12-,18+/m0/s1
| Molecular Formula | C20H16ClN5O2 |
| Molecular Weight | 393.826 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 11:38:07 UTC 2023
by
admin
on
Sat Dec 16 11:38:07 UTC 2023
|
| Record UNII |
4O87Q44KNC
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-RAD140
Created by
admin on Sat Dec 16 11:38:07 UTC 2023 , Edited by admin on Sat Dec 16 11:38:07 UTC 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1182367-47-0
Created by
admin on Sat Dec 16 11:38:07 UTC 2023 , Edited by admin on Sat Dec 16 11:38:07 UTC 2023
|
PRIMARY | |||
|
C137950
Created by
admin on Sat Dec 16 11:38:07 UTC 2023 , Edited by admin on Sat Dec 16 11:38:07 UTC 2023
|
PRIMARY | |||
|
DTXSID201032907
Created by
admin on Sat Dec 16 11:38:07 UTC 2023 , Edited by admin on Sat Dec 16 11:38:07 UTC 2023
|
PRIMARY | |||
|
11230
Created by
admin on Sat Dec 16 11:38:07 UTC 2023 , Edited by admin on Sat Dec 16 11:38:07 UTC 2023
|
PRIMARY | |||
|
DB13939
Created by
admin on Sat Dec 16 11:38:07 UTC 2023 , Edited by admin on Sat Dec 16 11:38:07 UTC 2023
|
PRIMARY | |||
|
300000017551
Created by
admin on Sat Dec 16 11:38:07 UTC 2023 , Edited by admin on Sat Dec 16 11:38:07 UTC 2023
|
PRIMARY | |||
|
44200882
Created by
admin on Sat Dec 16 11:38:07 UTC 2023 , Edited by admin on Sat Dec 16 11:38:07 UTC 2023
|
PRIMARY | |||
|
4O87Q44KNC
Created by
admin on Sat Dec 16 11:38:07 UTC 2023 , Edited by admin on Sat Dec 16 11:38:07 UTC 2023
|
PRIMARY | |||
|
RAD140
Created by
admin on Sat Dec 16 11:38:07 UTC 2023 , Edited by admin on Sat Dec 16 11:38:07 UTC 2023
|
PRIMARY | RAD140 is an investigational selective androgen receptor modulator (SARM) for the treatment of conditions such as muscle wasting, currently under development by Radius Health, Inc. (RDUS). |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
TARGET -> AGONIST |
SARM
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
